--- title: Montana’s plan to become an experimental medical hub... description: Montana has finalized rules implementing its expanded right-to-try law, creating a pathway for biotech companies to sell experimental drugs — including those... canonical: https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Montana’s plan to become an experimental medical hub just pushed forward | daily.dev og:description: Montana has finalized rules implementing its expanded right-to-try law, creating a pathway for biotech companies to sell experimental drugs — including those... og:url: https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v og:image: https://api.daily.dev/og/posts/8PDBlE29V.png og:image:alt: Montana’s plan to become an experimental medical hub just pushed forward og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Montana’s plan to become an experimental medical hub just pushed forward **[MIT Technology Review](https://daily.dev/sources/technologyreview)** · 12 min read · 0 upvotes · 0 comments ## Summary Montana has finalized rules implementing its expanded right-to-try law, creating a pathway for biotech companies to sell experimental drugs — including those tested in as few as 10 people — to any consenting adult, not just the terminally ill. A private review board called the Montana ETRB, organized under the Infinita umbrella and staffed by longevity researchers and a bioethicist, has been established to evaluate applications for $12,500 each. Two applications have already been submitted for drugs targeting neuropathy and hearing loss. Critics, including Harvard Medical School's Aaron Kesselheim, warn that phase I safety data is insufficient to protect patients, and some biotech companies fear FDA retaliation. Unlike the FDA's expanded-access program, Montana's law allows companies to charge market-rate prices, potentially reaching the median rare-disease drug price of over $218,000. The first experimental treatment clinics are expected to open by end of 2026. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: ## Similar posts on daily.dev - [The Download: Montana’s new experimental drug rules](https://daily.dev/posts/the-download-montana-s-new-experimental-drug-rules-nd9luaoak) · MIT Technology Review · 0 upvotes · 0 comments - [Montana’s new “right to try” law can’t come soon enough for some](https://daily.dev/posts/montana-s-new-right-to-try-law-can-t-come-soon-enough-for-some-6ls0awou8) · MIT Technology Review · 0 upvotes · 0 comments - [This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”](https://daily.dev/posts/this-company-is-developing-gene-therapies-for-muscle-growth-erectile-dysfunction-and-radical-long-rbtk4d1cc) · MIT Technology Review · 0 upvotes · 0 comments - [BioInnovation Institute Opens Applications for 2026 Venture Lab Program](https://daily.dev/posts/bioinnovation-institute-opens-applications-for-2026-venture-lab-program-y9bdyiabu) · The Quantum Insider · 0 upvotes · 0 comments --- Tags: [#biotech](https://daily.dev/tags/biotech) [View this post on daily.dev](https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Montana’s plan to become an experimental medical hub just pushed forward","url":"https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v"},"datePublished":"2026-07-30T17:42:36.951Z","dateModified":"2026-07-30T18:47:24.410Z","description":"Montana has finalized rules implementing its expanded right-to-try law, creating a pathway for biotech companies to sell experimental drugs — including those...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/577d8b44d9d211c3456f846e008018dc?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/577d8b44d9d211c3456f846e008018dc?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"MIT Technology Review","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"MIT Technology Review","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/a8d03889722f4f22b3986e0b395ff076","url":"https://daily.dev/sources/technologyreview"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/montana-s-plan-to-become-an-experimental-medical-hub-just-pushed-forward-8pdble29v","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"biotech","timeRequired":"PT12M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"MIT Technology Review","item":"https://daily.dev/sources/technologyreview"},{"@type":"ListItem","position":3,"name":"Montana’s plan to become an experimental medical hub just pushed forward"}]} ```